Karl Handelsman, Investment Director at the Roche Venture Fund
Karl has one of the best track records investing in early stage biotech therapeutic and synthetic biology companies over the last 18 years. He runs Codon Capital and is also an Investment Director at the Roche Venture Fund. Karl invests in seed and series A rounds with exits via M&A and IPOs for Billions of dollars. Karl is also a member of the Life Science Angels.